Pediatric Perfusion Products Market Trends

Growth Drivers

Growing Rate of Cardiac Birth Defects

The rising cases of cardiac birth defects such as congenital heart diseases are primarily driving the growth of the market around the world. Congenital means present at birth.  According to March of Dime, Nearly 1 in every 100 babies is born with a heart defect in the United States each year and about 1 in every 4 babies born (about 25 percent) has a critical CHD.

Increasing Demand for Non-Invasive Treatment

The demand for non-invasive or minimally invasive treatments to cure heart defects has increased. According to the Centers for Disease Control and Prevention (CDC), 16,800 babies in the U.S. are born each year with ventricular septal defects (VSD) which have elevated the demand of the products.

Additionally, increasing awareness around the new treatment of different heart abnormalities, effective technological advancements, and rising acceptance of pediatric perfusion products among consumers are anticipated to expedite the demand for pediatric perfusion products during the forecast period.

Challenges

High Cost

High cost accompanying pediatric cardiac heart surgeries in low-income nations might hamper the growth of the global pediatric perfusion products market during the forecast period.

Additionally, strict regulatory guidelines for pediatric perfusion devices and the lesser availability of pediatric heart surgeons and perfusionists are projected to hamper the growth of the global market.